|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002978,
umls-concept:C0008976,
umls-concept:C0022661,
umls-concept:C0022877,
umls-concept:C0030705,
umls-concept:C0063757,
umls-concept:C0063828,
umls-concept:C0377786,
umls-concept:C0403447,
umls-concept:C0599918,
umls-concept:C1274040,
umls-concept:C1565489,
umls-concept:C1948041
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-10-22
|
|
pubmed:abstractText |
Iso-osmolar contrast medium iodixanol has been reported to be less nephrotoxic than selected low-osmolar contrast media (LOCM) in chronic kidney disease (CKD) patients with diabetes mellitus. This study compared the nephrotoxicity of iodixanol and the LOCM ioversol in CKD patients undergoing coronary angiography.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
156
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
776-82
|
|
pubmed:meshHeading |
pubmed-meshheading:18946896-Aged,
pubmed-meshheading:18946896-Aged, 80 and over,
pubmed-meshheading:18946896-Contrast Media,
pubmed-meshheading:18946896-Coronary Angiography,
pubmed-meshheading:18946896-Coronary Disease,
pubmed-meshheading:18946896-Creatinine,
pubmed-meshheading:18946896-Diabetic Angiopathies,
pubmed-meshheading:18946896-Diabetic Nephropathies,
pubmed-meshheading:18946896-Double-Blind Method,
pubmed-meshheading:18946896-Female,
pubmed-meshheading:18946896-Humans,
pubmed-meshheading:18946896-Kidney,
pubmed-meshheading:18946896-Male,
pubmed-meshheading:18946896-Middle Aged,
pubmed-meshheading:18946896-Prospective Studies,
pubmed-meshheading:18946896-Renal Insufficiency, Chronic,
pubmed-meshheading:18946896-Triiodobenzoic Acids
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
|
|
pubmed:affiliation |
Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. rudnickm@uphs.upenn.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
